Susanne A Schneider1,2, Thomas Bird3,4. 1. Department of Neurology Ludwig-Maximilians-Universität München Munich Germany. 2. University of Kiel Kiel Germany. 3. Department of Neurology University of Washington Seattle Seattle Washington U.S.A. 4. VA Puget Sound Health Care System Geriatric Research Education and Clinical Center Seattle Washington U.S.A.
Abstract
BACKGROUND: The differential diagnosis of chorea syndromes is complex. It includes inherited forms, the most common of which is autosomal dominant Huntington's disease (HD). In addition, there are disorders mimicking HD, the so-called HD-like (HDL) syndromes. METHODS AND RESULTS: Here we review main clinical, genetic, and pathophysiological characteristics of HD and the rare HD phenocopies in order to familiarize clinicians with them. Molecular studies have shown that HD phenocopies account for about 1% of suspected HD cases, most commonly due to mutations in C9orf72 (also the main cause of frontotemporal dementia and amyotrophic lateral sclerosis syndromes), TATA box-binding protein (spinocerebellar ataxia type 17 [SCA17]/HDL4), and JPH3 (HDL2). Systematic screening studies also revealed mutations in PRNP (prion disease), VPS13A (chorea-acanthocytosis), ATXN8OS-ATXN8 (SCA8), and FXN (late-onset Friedreich's Ataxia) in single cases. Further differential diagnoses to consider in patients presenting with a clinical diagnosis consistent with HD, but without the HD expansion, include dentatorubral-pallidoluysian atrophy and benign hereditary chorea (TITF1), as well as the recently described form of ADCY5-associated neurodegeneration. Lastly, biallelic mutations in RNF216 and FRRS1L have recently been reported as autosomal recessive phenocopies of HD. CONCLUSION: There is a growing list of genes associated with chorea, yet a substantial percentage of patients remain undiagnosed. It is likely that more genes will be discovered in the future and that the clinical spectrum of the described disorders will broaden.
BACKGROUND: The differential diagnosis of chorea syndromes is complex. It includes inherited forms, the most common of which is autosomal dominant Huntington's disease (HD). In addition, there are disorders mimicking HD, the so-called HD-like (HDL) syndromes. METHODS AND RESULTS: Here we review main clinical, genetic, and pathophysiological characteristics of HD and the rare HD phenocopies in order to familiarize clinicians with them. Molecular studies have shown that HD phenocopies account for about 1% of suspected HD cases, most commonly due to mutations in C9orf72 (also the main cause of frontotemporal dementia and amyotrophic lateral sclerosis syndromes), TATA box-binding protein (spinocerebellar ataxia type 17 [SCA17]/HDL4), and JPH3 (HDL2). Systematic screening studies also revealed mutations in PRNP (prion disease), VPS13A (chorea-acanthocytosis), ATXN8OS-ATXN8 (SCA8), and FXN (late-onset Friedreich's Ataxia) in single cases. Further differential diagnoses to consider in patients presenting with a clinical diagnosis consistent with HD, but without the HD expansion, include dentatorubral-pallidoluysian atrophy and benign hereditary chorea (TITF1), as well as the recently described form of ADCY5-associated neurodegeneration. Lastly, biallelic mutations in RNF216 and FRRS1L have recently been reported as autosomal recessive phenocopies of HD. CONCLUSION: There is a growing list of genes associated with chorea, yet a substantial percentage of patients remain undiagnosed. It is likely that more genes will be discovered in the future and that the clinical spectrum of the described disorders will broaden.
Authors: Russell L Margolis; Susan E Holmes; Adam Rosenblatt; Lisa Gourley; Elizabeth O'Hearn; Christopher A Ross; William K Seltzer; Ruth H Walker; Tetsuo Ashizawa; Astrid Rasmussen; Michael Hayden; Elisabeth W Almqvist; Juliette Harris; Stanley Fahn; Marcy E MacDonald; Jayalakshmi Mysore; Takayoshi Shimohata; Shoji Tsuji; Nicholas Potter; Kazuhiro Nakaso; Yoshiki Adachi; Kenji Nakashima; Thomas Bird; Amanda Krause; Penny Greenstein Journal: Ann Neurol Date: 2004-11 Impact factor: 10.422
Authors: R C Moore; F Xiang; J Monaghan; D Han; Z Zhang; L Edström; M Anvret; S B Prusiner Journal: Am J Hum Genet Date: 2001-10-09 Impact factor: 11.025
Authors: S E Holmes; E O'Hearn; A Rosenblatt; C Callahan; H S Hwang; R G Ingersoll-Ashworth; A Fleisher; G Stevanin; A Brice; N T Potter; C A Ross; R L Margolis Journal: Nat Genet Date: 2001-12 Impact factor: 38.330
Authors: Arndt Rolfs; Arnulf H Koeppen; Ingrid Bauer; Peter Bauer; Sven Buhlmann; Helge Topka; Ludger Schöls; Olaf Riess Journal: Ann Neurol Date: 2003-09 Impact factor: 10.422
Authors: Kristina Ibañez; James Polke; R Tanner Hagelstrom; Egor Dolzhenko; Dorota Pasko; Ellen Rachel Amy Thomas; Louise C Daugherty; Dalia Kasperaviciute; Katherine R Smith; Zandra C Deans; Sue Hill; Tom Fowler; Richard H Scott; John Hardy; Patrick F Chinnery; Henry Houlden; Augusto Rendon; Mark J Caulfield; Michael A Eberle; Ryan J Taft; Arianna Tucci Journal: Lancet Neurol Date: 2022-03 Impact factor: 59.935
Authors: Francesca Becherucci; Samuela Landini; Luigi Cirillo; Benedetta Mazzinghi; Paola Romagnani Journal: Int J Environ Res Public Health Date: 2020-11-12 Impact factor: 3.390
Authors: Carlos Alva-Diaz; Christoper A Alarcon-Ruiz; Kevin Pacheco-Barrios; Nicanor Mori; Josmel Pacheco-Mendoza; Bryan J Traynor; Andrea Rivera-Valdivia; Pongtawat Lertwilaiwittaya; Thomas D Bird; Mario Cornejo-Olivas Journal: Front Genet Date: 2020-11-02 Impact factor: 4.599